| Abstract: |
A human monoclonal antibody Pez.2F5, produced by a lymphoblastoid cell line, has been established in vitro by Epstein-Barr virus (EBV) transformation of B lymphocytes isolated from the blood of a volunteer immunized with allogenic peripheral blood leukocytes (PBLs). The antibody reacted with a new supertypic determinant expressed on all lymphoblastoid cell lines homozygous for HLA-DR1, -2, and -w9. The genetic linkage of the Pez.2F5 determinant to the HLA region was demonstrated by family segregation studies. Quantitative absorption studies indicated that DR2-positive cells required more Pez.2F5 antibody for lysis, and since their absorption capacity was significantly lower than that of DRI- or DRw9-positive cells, it is likely that the Pez.2F5 determinant of the DR2 halotype is crossreactive but not identical with the determinant found on the latter haplotypes. In addition, on a test panel of HLA-typed B lymphocytes, Pez.2F5 showed perfect correlation with DRI and DRw9, but reacted with only a fraction of DR2-positive cells. The Pez.2F5 determinant was found to be absent from resting T lymphocytes, but its expression could be identified on IL-2-dependent T-cell lines by cytotoxicity and flow cytofluorometric analysis. By sequential immunoprecipitation and SDS gel analysis of antigens of DR1 cells it was determined that the Pez.2F5 determinant is carried by HLA class II DR molecules. Thus, the Pez.2F5 is the first described human monoclonal antibody able to immunoprecipitate HLA class II-related molecules. © 1988. |
| Keywords: |
human cell; t-lymphocytes; phenotype; monoclonal antibody; fluorescent antibody technique; antibodies, monoclonal; cell culture; hla dr antigen; major histocompatibility antigen class 2; hla-dr antigens; immunoprecipitation; hla-d antigens; normal human; lymphoblastoid cell line; in vitro; electrophoresis, polyacrylamide gel; human experiment; epitopes; cross reactions; antigen-antibody complex; human; hla-dr1 antigen; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; hla-dr2 antigen
|
